Saw, Robyn P M <br/><br/>
Adjuvant therapy with high dose vitamin D following primary treatment of melanoma at high risk of recurrence: a placebo controlled randomised phase II trial (ANZMTG 02.09 Mel-D).  [electronic resource] 

 -  BMC cancer  Oct 2014 
 - 780 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1471-2407 
<br/><br/><label>Standard No.: </label>10.1186/1471-2407-14-780  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Chemotherapy, Adjuvant<br/>Clinical Protocols<br/>Humans<br/>Melanoma--drug therapy<br/>Neoplasm Recurrence, Local<br/>Neoplasm Staging<br/>Skin Neoplasms<br/>Vitamin D--administration & dosage<br/>Melanoma, Cutaneous Malignant